Paper32037523
Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma.
Wu X and 16 others. Br J Haematol, 2020. Cited by 60 papers, by iCite.
Cite this record
ConductScience Library. Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma. Papers, record 32037523. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32037523
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Bortezomib | Major topic |
| Glutathione | Major topic |
| Multiple Myeloma | Major topic |
| Phosphoglycerate Dehydrogenase | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Humans | |
| Mice |
Source PubMed
Grants17
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 198465 | Postdoctoral Science Foundation of Central South University | International | PubMed | PubMed | |
| ZLXD2017004 | Strategic Priority Research Program of Central South University | International | PubMed | PubMed | |
| 2018M640762 | China Postdoctoral Science Foundation | International | PubMed | PubMed | |
| 2018YFA0107800 | Ministry of Science and Technology of China | International | PubMed | PubMed | |
| 81570205 | National Natural Science Foundation of China | International | PubMed | PubMed | |
| 81630007 | National Natural Science Foundation of China | International | PubMed | PubMed | |
| 81800209 | National Natural Science Foundation of China | International | PubMed | PubMed | |
| 81974010 | National Natural Science Foundation of China | International | PubMed | PubMed | |
| 2019JJ50838 | Hunan Province Natural Science Foundation of China | International | PubMed | PubMed | |
| 2018zzts079 | Fundamental Research Funds for the Central Universities of Central South University | International | PubMed | PubMed | |
| 2019zzts1010 | Fundamental Research Funds for the Central Universities of Central South University | International | PubMed | PubMed | |
| 2019zzts177 | Fundamental Research Funds for the Central Universities of Central South University | International | PubMed | PubMed | |
| 2019zzts716 | Fundamental Research Funds for the Central Universities of Central South University | International | PubMed | PubMed | |
| 2019zzts717 | Fundamental Research Funds for the Central Universities of Central South University | International | PubMed | PubMed | |
| CX20190233 | Hunan Provincial Innovation Foundation for Postgraduates | International | PubMed | PubMed | |
| CSUZC201948 | Open Sharing Fund for the Large-scale Instruments And Equipments of Central South University | International | CSUZC201948 | PubMed | NIH RePORTER |
| CSUZC201949 | Open Sharing Fund for the Large-scale Instruments And Equipments of Central South University | International | CSUZC201949 | PubMed | NIH RePORTER |
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42724467 | PHGDH in cancer: a narrative review of its functions beyond serine metabolism. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42724467 | PubMed |
| 41725790 | The role of antioxidants in multiple myeloma: diagnostic, prognostic, and therapeutic applications: a narrative review. | Ther Adv Hematol | 2026 | https://conductscience.org/library/papers/41725790 | PubMed |
| 41674932 | PHGDH knockdown activates autophagic flux to suppress migration and invasion of gastric cancer cells. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/41674932 | PubMed |
| 41486146 | PHGDH at the crossroads: metabolic plasticity, metastatic paradoxes, and therapeutic reconnaissance in cancer. | J Biomed Sci | 2026 | https://conductscience.org/library/papers/41486146 | PubMed |
| 41398969 | Nutritional approaches in combating therapeutic resistance and enhancing treatment efficacy in cancer: the impact of ketogenic diets. | Nutr Metab (Lond) | 2025 | https://conductscience.org/library/papers/41398969 | PubMed |
| 40919131 | Metabolic Reprogramming: A Crucial Contributor to Anticancer Drug Resistance. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40919131 | PubMed |
| 40616775 | Clioquinol as a new therapy in epilepsy: From preclinical evidence to a proof-of-concept clinical study. | Epilepsia | 2025 | https://conductscience.org/library/papers/40616775 | PubMed |
| 40200920 | The oligosaccharyltransferase complex is an essential component of multiple myeloma plasma cells. | Mol Ther Oncol | 2025 | https://conductscience.org/library/papers/40200920 | PubMed |
| 39962071 | MAPK13 phosphorylates PHGDH and promotes its degradation via chaperone-mediated autophagy during liver injury. | Cell Discov | 2025 | https://conductscience.org/library/papers/39962071 | PubMed |
| 39595653 | Supplementation of Oocytes by Microinjection with Extra Copies of mtDNA Alters Metabolite Profiles and Interactions with Expressed Genes in a Tissue-Specific Manner. | Biomolecules | 2024 | https://conductscience.org/library/papers/39595653 | PubMed |
| 39201634 | Different Strategies to Overcome Resistance to Proteasome Inhibitors-A Summary 20 Years after Their Introduction. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39201634 | PubMed |
| 38791048 | Cellular Responses Induced by NCT-503 Treatment on Triple-Negative Breast Cancer Cell Lines: A Proteomics Approach. | Biomedicines | 2024 | https://conductscience.org/library/papers/38791048 | PubMed |
| 38615172 | Mechanisms of the role of proto-oncogene activation in promoting malignant transformation of mature B cells. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2024 | https://conductscience.org/library/papers/38615172 | PubMed |
| 38577610 | PHGDH is Key to a Prognostic Multigene Signature and a Potential Therapeutic Target in Acute Myeloid Leukemia. | J Cancer | 2024 | https://conductscience.org/library/papers/38577610 | PubMed |
| 38500772 | Factors determining the sensitivity to proteasome inhibitors of multiple myeloma cells. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38500772 | PubMed |
| 37587064 | High expression of VARS promotes the growth of multiple myeloma cells by causing imbalance in valine metabolism. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2023 | https://conductscience.org/library/papers/37587064 | PubMed |
| 37248571 | [Latest Findings on the Mechanism of the Interaction Between Multiple Myeloma Cells and Bone Marrow Microenvironment]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2023 | https://conductscience.org/library/papers/37248571 | PubMed |
| 37190313 | The Ubiquitin-Proteasome System in Tumor Metabolism. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37190313 | PubMed |
| 37190210 | Intestinal Microbes and Hematological Malignancies. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37190210 | PubMed |
| 37187454 | Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment. | Adv Nutr | 2023 | https://conductscience.org/library/papers/37187454 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PHGDH | 26227 | PubTator's text mining | https://conductscience.org/library/genes/26227 | NCBI Gene |
| SDC1 | 6382 | PubTator's text mining | https://conductscience.org/library/genes/6382 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32037523
GET https://conductscience.org/api/papers/v1/32037523/cited_by?page=2